David R. Wildman specializes in complex transactions involving technology, intellectual property, and data. In this role, he regularly advises clients on issues relating to data commercialization, IP licensing, software development, and information technology services (such as cloud services, IT procurement, and outsourcing).
Mr. Wildman, who is a registered Patent Attorney and former electrical engineer, also advises on the intellectual property aspects of mergers, acquisitions, and strategic investments. Mr. Wildman represents clients in a wide array of industries, including health technology, travel, and finance.
In addition to his broader practice, Mr. Wildman is a member of Covington’s Digital Health Initiative. In that capacity, he counsels pharmaceutical, medical device, and technology companies on the complex commercial and intellectual property considerations that arise at the intersection of information technology, life sciences, and healthcare.
These considerations include patient privacy and data security, ownership of data and derived insights, service levels, the development and exploitation of “Big Data” analytical tools and predictive models, and FDA-readiness, as well as other commercial issues that arise when entering into a partnership, collaboration or other strategic arrangement with participants in the digital health sector.
Mr. Wildman also has extensive experience in the management and strategic development of patent portfolios in a variety of technical disciplines, which he leverages to help clients develop holistic intellectual property strategies that align to business objectives.
Before joining the firm, Mr. Wildman worked at another leading law firm prosecuting patent applications in the U.S. and abroad, representing clients in post-grant proceedings at the United States Patent & Trademark Office (USPTO), conducting due diligence analyses, and rendering opinions on patent validity, infringement, and freedom-to-operate.
Mr. Wildman holds a degree in Electrical Engineering from Columbia University and obtained his J.D. from New York University School of Law. Prior to his legal career, Mr. Wildman worked as a wireless design engineer in the mobile device industry.
- New York University School of Law, J.D., 2013
- Columbia University, B.S., 2007
Bar Admissions :
- New York
Representative Matters :
- GlaxoSmithKline on its multi-year drug target discovery and development collaboration with 23andMe.
- Teva Pharmaceutical Industries in its strategic partnership with IBM, including the deployment of IBM’s Watson Health Cloud as Teva’s global patient technology platform.
- American Airlines in technology and data distribution agreements with travel industry participants.
- Various airlines in connection with agency agreements, data commercialization agreements, data distribution agreements, and IT services agreements.
- A multinational biopharmaceutical company in connection with an acquisition of a biotechnology company specializing in CRISPR-based technologies for target discovery.
Pro Bono :
- Obtained Special Immigrant Juvenile Status (SIJS) for a minor from El Salvador in removal proceedings.
- Advised a 501(c)(3) organization in connection with an agreement for customer relationship management (CRM) software and consulting services.
- Advised the founder of a fitness company directed at low income individuals on corporate and intellectual property matters, including with respect to entity formation, trademark filings, client agreements, and publicity waivers.
Previous Experience :
- Performed IP due diligence on behalf of an investor participating in a Series C funding round of a medical device company.
- Facilitated the development of a global licensing program, involving thousands of IP assets, for a leading media company.
- Represented a Fortune 500 company in an inter partes review at the USPTO.
Rate : $$$